Literature DB >> 1283324

Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.

D T Ransom1, S R Ritland, D W Kimmel, C A Moertel, R J Dahl, B W Scheithauer, P J Kelly, R B Jenkins.   

Abstract

Cytogenetic and/or loss of heterozygosity studies were performed on 13 ependymomas, 11 pilocytic astrocytomas, and 18 oligodendrogliomas. Loss of chromosome 22 was the most frequent genetic abnormality among the ependymomas. We found no consistent genetic abnormality in pilocytic astrocytomas. The most common genetic abnormality in oligodendrogliomas was loss of a portion of chromosome 19. Each informative oligodendroglioma had loss of alleles mapped to the long arm (q) of chromosome 19. One oligodendroglioma had an apparent homozygous deletion of the D19S8 locus. Our results, when combined with those in the literature, indicate that chromosomes 9, 11, and 22 may harbor genes important for the pathogenesis of ependymomas and that 19q probably harbors a gene important for the pathogenesis of oligodendrogliomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283324     DOI: 10.1002/gcc.2870050411

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  32 in total

Review 1.  Glioma classification: a molecular reappraisal.

Authors:  D N Louis; E C Holland; J G Cairncross
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Infrequency of p53 gene mutations in ependymomas.

Authors:  K L Fink; E J Rushing; S C Schold; P D Nisen
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

3.  Recurrent anaplastic ependymoma with an abnormal karyotype and c-myc proto-oncogene overexpression.

Authors:  M Debiec-Rychter; J Lasota; J Alwasiak; P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Intracranial ependymoma associated with multiple endocrine neoplasia type 1.

Authors:  A Al-Salameh; P François; S Giraud; A Calender; A-M Bergemer-Fouquet; L de Calan; P Goudet; P Lecomte
Journal:  J Endocrinol Invest       Date:  2010-02-05       Impact factor: 4.256

5.  The genomics of brain cancer.

Authors:  Sarah DeWeerdt
Journal:  Nature       Date:  2018-09       Impact factor: 49.962

Review 6.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

7.  Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.

Authors:  Fabio M Iwamoto; Linda Nicolardi; Alexis Demopoulos; Violetta Barbashina; Paulo Salazar; Marc Rosenblum; Adília Hormigo
Journal:  J Neurooncol       Date:  2008-03-15       Impact factor: 4.130

Review 8.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

9.  Rig is a novel Ras-related protein and potential neural tumor suppressor.

Authors:  Chad A Ellis; Michele D Vos; Heather Howell; Teresa Vallecorsa; Daniel W Fults; Geoffrey J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-09       Impact factor: 11.205

10.  A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor.

Authors:  Takashi Yokota; Takayuki Tachizawa; Koichi Fukino; Akira Teramoto; Jun Kouno; Koshi Matsumoto; Mitsuru Emi
Journal:  J Hum Genet       Date:  2003-10-18       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.